Gene expression in mononuclear cells from patients with inflammatory bowel disease

被引:25
作者
Mannick, EE
Bonomolo, JC
Horswell, R
Lentz, JJ
Serrano, MS
Zapata-Velandia, A
Gastanaduy, M
Himel, JL
Rose, SL
Udall, JN
Hornick, CA
Liu, ZY
机构
[1] Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Inflammatory Bowel Dis Ctr Excellence, New Orleans, LA 70112 USA
[3] Louisiana State Univ, Dept Physiol, New Orleans, LA 70112 USA
[4] Prometheus Labs, San Diego, CA 92121 USA
关键词
Crohn's disease; microarray; mononuclear cell;
D O I
10.1016/j.clim.2004.03.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives. Discovery of Nod2 as the inflammatory bowel disease 1 (IBD1) susceptibility gene has brought to light the significance of mononuclear cells in inflammatory bowel disease pathogenesis. The purpose of this study was to examine changes in gene expression in peripheral blood mononuclear cells in patients with untreated Crohn's disease (CD) and ulcerative colitis (UC) as compared to patients with other inflammatory gastrointestinal disorders and to healthy controls. Methods. We used a 2400 gene cDNA glass slide array (MICROMAX(TM)) to examine gene expression in peripheral blood mononuclear cells from seven patients with Crohn's disease, five patients with ulcerative colitis, 10 patients with other inflammatory gastrointestinal disorders, and 22 age- and sex-matched controls. Results. Novel categories of genes differentially expressed in Crohn's disease and ulcerative colitis patients included genes regulating hematopoietic cell differentiation and leukemogenesis, lipid raft-associated signaling, the actin cytoskeleton, and vesicular trafficking. Conclusions. Altered gene expression in mononuclear cells may contribute to inflammatory bowel disease pathogenesis. (C) 2004 Published by Elsevier Inc.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 116 条
  • [1] T cell activation and the cytoskeleton
    Acuto, O
    Cantrell, D
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 165 - +
  • [2] Agrawal D, 2002, J NATL CANCER I, V94, P513
  • [3] NF-κB activation in cancer:: a challenge for ubiquitination- and proteasome-based therapeutic approach
    Amit, S
    Ben-Neriah, Y
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) : 15 - 28
  • [4] RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression
    Aoki, K
    Meng, GY
    Suzuki, K
    Takashi, T
    Kameoka, Y
    Nakahara, K
    Ishida, R
    Kasai, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) : 26698 - 26704
  • [5] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [6] Interactions of phocein with nucleoside-diphosphate kinase, Eps15, and dynamin I
    Baillat, G
    Gaillard, S
    Castets, F
    Monneron, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) : 18961 - 18966
  • [7] Basbaum C, 2002, NOVART FDN SYMP, V248, P171
  • [8] ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS
    BASU, TN
    GUTMANN, DH
    FLETCHER, JA
    GLOVER, TW
    COLLINS, FS
    DOWNWARD, J
    [J]. NATURE, 1992, 356 (6371) : 713 - 715
  • [9] Gene structure and tissue expression of human selenoprotein W, SEPW1, and identification of a retroprocessed pseudogene, SEPW1P
    Bellingham, J
    Gregory-Evans, K
    Fox, MF
    Gregory-Evans, CY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2003, 1627 (2-3): : 140 - 146
  • [10] The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation
    Bentham, M
    Mazaleyrat, S
    Harris, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 2705 - 2713